Steroids and brain atrophy in multiple sclerosis

Journal of the Neurological Sciences

Volumn 233, Issue 1-2, 2005, Pages 73-81

  Zivadinov, Robert ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b JACOBS NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Autoimmune disease; Brain atrophy; Brain volume fluctuation; MRI; Multiple sclerosis; Nonhuman primate; Pathogenetic mechanisms; Steroid therapy

Indexed keywords

CELL ADHESION MOLECULE; CORTICOSTEROID; CYTOKINE; MATRIX METALLOPROTEINASE; METHYLPREDNISOLONE;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; BRAIN ATROPHY; BRAIN SIZE; CONFERENCE PAPER; CORTICOSTEROID THERAPY; DEMYELINATION; DEWATERING; DRUG MEGADOSE; DRUG SENSITIVITY; ENZYME RELEASE; EVIDENCE BASED MEDICINE; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INHIBITION KINETICS; LOW DRUG DOSE; MULTIPLE SCLEROSIS; NERVE FIBER; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; REMYELINIZATION; SIDE EFFECT; T LYMPHOCYTE;

ANIMALS; ATROPHY; BRAIN DISEASES; HUMANS; MULTIPLE SCLEROSIS; STEROIDS; TIME FACTORS;

EID: 20444390127     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2005.03.006     Document Type: Conference Paper

References (102)

1. G. Filippini, F. Brusaferri, W.A. Sibley, A. Citterio, G. Ciucci, and R. Midgard Corticosteroids or ACTH for acute exacerbations in multiple sclerosis Cochrane Database Syst Rev 4 2000 CD001331
2. D.M. Miller, B. Weinstock-Guttman, F. Bethoux, J.C. Lee, G. Beck, and V. Block A meta-analysis of methylprednisolone in recovery from multiple sclerosis exacerbations Mult Scler 6 4 2000 267 273
3. F. Brusaferri, and L. Candelise Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials J Neurol 247 2000 435 442
4. R.W. Beck, P.A. Cleary, J.D. Trobe, D.I. Kaufman, M.J. Kupersmith, and D.W. Paty The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group N Engl J Med 329 24 1993 1764 1769
5. R. Zivadinov, R.A. Rudick, R. De Masi, D. Nasuelli, M. Ukmar, and R.S. Pozzi-Mucelli Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS Neurology 57 7 2001 1239 1247
6. D.E. Goodkin, R.P. Kinkel, B. Weinstock-Guttman, S. VanderBrug-Medendorp, M. Secic, and D. Gogol A phase II study of i.v. methylprednisolone in secondary-progressive multiple sclerosis Neurology 51 1 1998 239 245
7. The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial. Optic Neuritis Study Group Neurology 49 1997 1404 1413
8. R.W. Beck, J.D. Trobe, P.S. Moke, R.L. Gal, D. Xing, and M.T. Bhatti High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial Arch Ophthalmol 121 7 2003 944 949
9. D.H. Miller, F. Barkhof, J.A. Frank, G.J. Parker, and A.J. Thompson Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance Brain 125 2002 1676 1695
10. R. Zivadinov, and R. Bakshi Role of MRI in multiple sclerosis. II. Brain and spinal cord atrophy Front Biosci 9 2004 647 664
11. R. Zivadinov, and R. Bakshi Neurological disability and central nervous system atrophy in multiple sclerosis J Neuroimaging 14 3 Suppl 2004 S27 S35
12. P.D. Molyneux, L. Kappos, C. Polman, C. Pozzilli, F. Barkhof, and M. Filippi The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis Brain 123 Pt 11 2000 2256 2263
13. R. Zivadinov, and M. Zorzon Is gadolinium enhancement predictive of the development of brain atrophy in multiple sclerosis? A review of the literature J Neuroimaging 12 2002 302 309
14. R.J. Raskin, D.J. Schnapf, and I. Mehlman Corticosteroid hormonal influence on cranial computerized tomography: observations in the Rhesus monkey J Rheumatol 10 1983 977 980
15. H. Uno, S. Eisele, A. Sakai, S. Shelton, E. Baker, and O. DeJesus Neurotoxicity of glucocorticoids in the primate brain Horm Behav 28 4 1994 336 348
16. J. Benston, M. Reza, J. Winter, and G. Wilson Steroids and apparent cerebral atrophy on computed tomography scans JCAT 2 1978 16 23
17. R.M. Sapolsky Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders Arch Gen Psychiatry 57 2000 925 935
18. I. Lagenstein, R.P. Willig, and D. Kuhne Reversible cerebral atrophy caused by corticotrophin Lancet 1 1979 1246 1247
19. I. Lagenstein, R.P. Willig, and D. Kuhne Cranial computed tomography (CCT) findings in children treated with ACTH and dexamethasone: first results Neuropadiatrie 10 1979 370 384
20. N. Gordon Apparent cerebral atrophy in patients on treatment with steroids Dev Med Child Neurol 22 1980 502 506
21. R.A. Rudick, E. Fisher, J.C. Lee, J. Simon, and L. Jacobs Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group Neurology 53 1999 1698 1704
22. A.B. Rao, N. Richert, T. Howard, B.K. Lewis, C.N. Bash, and H.F. McFarland Methylprednisolone effect on brain volume and enhancing lesions in MS before and during IFNbeta-1b Neurology 59 5 2002 688 694
23. E.L. Hoogervorst, C.H. Polman, and F. Barkhof Cerebral volume changes in multiple sclerosis patients treated with high-dose intravenous methylprednisolone Mult Scler 8 2002 415 419
24. A. Pato-Pato, J.M. Prieto, M. Lema, D. Dapena-Bolano, J. Abella-Corral, and J.M. Pumar Cerebral atrophy in multiple sclerosis patients treated periodically with boluses of methylprednisolone Rev Neurol 37 6 2003 501 506
25. N.V. Patel, and C.E. Finch The glucocorticoid paradox of caloric restriction in slowing brain aging Neurobiol Aging 23 2002 707 717
26. B.G. Neville, and J. Wilson Benign intracranial hypertension following corticosteroid withdrawal in childhood Br Med J 3 1970 554 556
27. M.A. Ron, W. Acker, G.K. Shaw, and W.A. Lishman Computerized tomography of the brain in chronic alcoholism: a survey and follow-up study Brain 105 1982 497 514
28. K. Kohlmeyer, G. Lehmkuhl, and F. Poutska Computed tomography of anorexia nervosa AJNR Am J Neuroradiol 4 1983 437 438
29. V.W. Swayze 2nd, A.E. Andersen, N.C. Andreasen, S. Arndt, Y. Sato, and S. Ziebell Brain tissue volume segmentation in patients with anorexia nervosa before and after weight normalization Int J Eat Disord 33 1 2003 33 44
30. A.R. Mellanby, and M.A. Reveley Effects of acute dehydration on computerized tomographic assessment of cerebral density and ventricular volume Lancet 2 1982 874
31. J.M. Verret Neuropsychiatric disorders in systemic lupus erythematosus: a general review (author's transl) Ann Med Interne 132 1981 205 214
32. S. Carette, M.B. Urowitz, H. Grosman, and E.L. St Louis Cranial computerized tomography in systemic lupus erythematosus J Rheumatol 9 1982 855 859
33. E. Menzano, and P.L. Carlen Zinc deficiency and corticosteroids in the pathogenesis of alcoholic brain dysfunction-a review Alcohol Clin Exp Res 18 1994 895 901
34. G.W. Hesse, K.A. Hesse, and F.A. Catalanotto Behavioral characteristics of rats experiencing chronic zinc deficiency Physiol Behav 22 1979 211 215
35. A. Pfefferbaum, D.H. Mathalon, E.V. Sullivan, J.M. Rawles, R.B. Zipursky, and K.O. Lim A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood Arch Neurol 51 9 1994 874 887
36. J. Fontaine, J. Neve, A. Peretz, P. Capel, and J.P. Famaey Effects of acute and chronic prednisolone treatment on serum zinc levels in rats with adjuvant arthritis Agents Actions 33 1991 247 253
37. K.R. Etzel, S.G. Shapiro, and R.J. Cousins Regulation of liver metallothionein and plasma zinc by the glucocorticoid dexamethasone Biochem Biophys Res Commun 89 1979 1120 1126
38. K.J. Momose, R.N. Kjellberg, and B. Kliman High incidence of cortical atrophy of the cerebral and cerebellar hemispheres in Cushing's disease Radiology 99 1971 341 348
39. P.B. Andersson, and D.E. Goodkin Glucocorticosteroid therapy for multiple sclerosis: a critical review J Neurol Sci 160 1998 16 25
40. E. Falkenstein, H.C. Tillmann, M. Christ, M. Feuring, and M. Wehling Multiple actions of steroid hormones-a focus on rapid, nongenomic effects Pharmacol Rev 52 2000 513 556
41. R. Gold, F. Buttgereit, and K.V. Toyka Mechanism of action of glucocorticosteroid hormones: possible implications for therapy of neuroimmunological disorders J Neuroimmunol 117 2001 1 8
42. J.J. Watters, J.S. Campbell, M.J. Cunningham, E.G. Krebs, and D.M. Dorsa Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription Endocrinology 138 1997 4030 4033
43. F. Nakazawa, H. Matsuno, K. Yudoh, Y. Watanabe, R. Katayama, and T. Kimura Corticosteroid treatment induces chondrocyte apoptosis in an experimental arthritis model and in chondrocyte cultures Clin Exp Rheumatol 20 6 2002 773 781
44. D.R. Dorscheid, K.R. Wojcik, S. Sun, B. Marroquin, and S.R. White Apoptosis of airway epithelial cells induced by corticosteroids Am J Respir Crit Care Med 164 2001 1939 1947
45. R. Meyer, R. Weissert, R. Diem, M.K. Storch, K.L. de Graaf, and B. Kramer Acute neuronal apoptosis in a rat model of multiple sclerosis J Neurosci 21 16 2001 6214 6220
46. R. Diem, M. Hobom, K. Maier, R. Weissert, M.K. Storch, and R. Meyer Methylprednisolone increases neuronal apoptosis during autoimmune CNS inflammation by inhibition of an endogenous neuroprotective pathway J Neurosci 23 18 2003 6993 7000
47. A. Stefferl, U. Brehm, M. Storch, D. Lambracht-Washington, C. Bourquin, and K. Wonigeit Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the "resistant" Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response J Immunol 163 1 1999 40 49
48. G. Cazzato, T. Mesiano, R. Antonello, F. Monti, N. Carraro, and P. Torre Double-blind, placebo-controlled, randomized, crossover trial of high-dose methylprednisolone in patients with chronic progressive form of multiple sclerosis Eur Neurol 35 4 1995 193 198
49. P.A. Brex, R. Jenkins, N.C. Fox, W.R. Crum, J.I. O'Riordan, and G.T. Plant Detection of ventricular enlargement in patients at the earliest clinical stage of MS Neurology 54 8 2000 1689 1691
50. B.D. Trapp, R. Ransohoff, and R. Rudick Axonal pathology in multiple sclerosis: relationship to neurologic disability Curr Opin Neurol 12 1999 295 302
51. M.R. Kaplan, A. Meyer-Franke, S. Lambert, V. Bennett, I.D. Duncan, and S.R. Levinson Induction of sodium channel clustering by oligodendrocytes Nature 386 6626 1997 724 728
52. F.W. Pfrieger, and B.A. Barres Synaptic efficacy enhanced by glial cells in vitro Science 277 1997 1684 1687
53. R. Bakshi, R.H. Benedict, R.A. Bermel, S.D. Caruthers, S.R. Puli, and C.W. Tjoa T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study Arch Neurol 59 1 2002 62 68
54. E. Gould, A. Beylin, P. Tanapat, A. Reeves, and T.J. Shors Learning enhances adult neurogenesis in the hippocampal formation Nat Neurosci 2 1999 260 265
55. L.P. Reagan, and B.S. McEwen Controversies surrounding glucocorticoid-mediated cell death in the hippocampus J Chem Neuroanat 13 1997 149 167
56. R.S. Sloviter, G. Valiquette, G.M. Abrams, E.C. Ronk, A.L. Sollas, and L.A. Paul Selective loss of hippocampal granule cells in the mature rat brain after adrenalectomy Science 243 4890 1989 535 538
57. T.S. Jensen, I.K. Genefke, N. Hyldebrandt, H. Pedersen, H.D. Petersen, and B. Weile Cerebral atrophy in young torture victims N Engl J Med 307 21 1982 1341
58. J.D. Bremner, P. Randall, T.M. Scott, R.A. Bronen, J.P. Seibyl, and S.M. Southwick MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder Am J Psychiatry 152 7 1995 973 981
59. T.V. Gurvits, M.E. Shenton, H. Hokama, H. Ohta, N.B. Lasko, and M.W. Gilbertson Magnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder Biol Psychiatry 40 11 1996 1091 1099
60. M.B. Stein, C. Koverola, C. Hanna, M.G. Torchia, and B. McClarty Hippocampal volume in women victimized by childhood sexual abuse Psychol Med 27 1997 951 959
61. J.D. Bremner, P. Randall, E. Vermetten, L. Staib, R.A. Bronen, and C. Mazure Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse-a preliminary report Biol Psychiatry 41 1 1997 23 32
62. M.N. Starkman, S.S. Gebarski, S. Berent, and D.E. Schteingart Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome Biol Psychiatry 32 1992 756 765
63. M.N. Starkman, B. Giordani, S.S. Gebarski, S. Berent, M.A. Schork, and D.E. Schteingart Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease Biol Psychiatry 46 12 1999 1595 1602
64. P. Villoslada, and C.P. Genain Role of nerve growth factor and other trophic factors in brain inflammation Prog Brain Res 146 2004 403 414
65. M.A. Smith, S. Makino, R. Kvetnansky, and R.M. Post Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus J Neurosci 15 1995 1768 1777
66. I. Elovaara, M. Ukkonen, M. Leppakynnas, T. Lehtimaki, M. Luomala, and J. Peltola Adhesion molecules in multiple sclerosis: relation to subtypes of disease and methylprednisolone therapy Arch Neurol 57 4 2000 546 551
67. I. Elovaara, M. Lalla, E. Spare, T. Lehtimaki, and P. Dastidar Methylprednisolone reduces adhesion molecules in blood and cerebrospinal fluid in patients with MS Neurology 51 1998 1703 1708
68. A.G. Droogan, A.D. Crockard, S.A. McMillan, and S.A. Hawkins Effects of intravenous methylprednisolone therapy on leukocyte and soluble adhesion molecule expression in MS Neurology 50 1998 224 229
69. G.A. Rosenberg, J.E. Dencoff, N. Correa Jr., M. Reiners, and C.C. Ford Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury Neurology 46 1996 1626 1632
70. F. Sellebjerg, M. Christiansen, J. Jensen, and J.L. Frederiksen Immunological effects of oral high-dose methylprednisolone in acute optic neuritis and multiple sclerosis Eur J Neurol 7 2000 281 289
71. D.A. Joyce, J.H. Steer, and L.J. Abraham Glucocorticoid modulation of human monocyte/macrophage function: control of TNF-alpha secretion Inflamm Res 46 1997 447 451
72. H.Y. Wang, M. Matsui, S. Araya, N. Onai, K. Matsushima, and T. Saida Immune parameters associated with early treatment effects of high-dose intravenous methylprednisolone in multiple sclerosis J Neurol Sci 216 1 2003 61 66
73. F. Zipp, U. Wendling, M. Beyer, U. Grieger, S. Waiczies, and B. Wagenknecht Dual effect of glucocorticoids on apoptosis of human autoreactive and foreign antigen-specific T cells J Neuroimmunol 110 1-2 2000 214 222
74. M. Gelati, E. Corsini, M. De Rossi, L. Masini, G. Bernardi, and G. Massa Methylprednisolone acts on peripheral blood mononuclear cells and endothelium in inhibiting migration phenomena in patients with multiple sclerosis Arch Neurol 59 5 2002 774 780
75. J.W. Prineas, E.E. Kwon, P.Z. Goldenberg, E.S. Cho, and L.R. Sharer Interaction of astrocytes and newly formed oligodendrocytes in resolving multiple sclerosis lesions Lab Invest 63 1990 624 636
76. K.D. Pavelko, B.G. van Engelen, and M. Rodriguez Acceleration in the rate of CNS remyelination in lysolecithin-induced demyelination J Neurosci 18 1998 2498 2505
77. N.R. Ghatak, R.T. Leshner, A.C. Price, and W.L. Felton III Remyelination in the human central nervous system J Neuropathol Exp Neurol 48 1989 507 518
78. R. Troiano, M. Hafstein, M. Ruderman, P. Dowling, and S. Cook Effect of high-dose intravenous steroid administration on contrast-enhancing computed tomographic scan lesions in multiple sclerosis Ann Neurol 15 1984 257 263
79. J. Kesselring, D.H. Miller, D.G. MacManus, G. Johnson, N.M. Milligan, and N. Scolding Quantitative magnetic resonance imaging in multiple sclerosis: the effect of high dose intravenous methylprednisolone J Neurol Neurosurg Psychiatry 52 1 1989 14 17
80. J.A. Burnham, R.R. Wright, J. Dreisbach, and R.S. Murray The effect of high-dose steroids on MRI gadolinium enhancement in acute demyelinating lesions Neurology 41 1991 1349 1354
81. F. Barkhof, O.R. Hommes, P. Scheltens, and J. Valk Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis Neurology 41 1991 1219 1222
82. F. Barkhof, S.T. Frequin, O.R. Hommes, K. Lamers, P. Scheltens, and W.J. van Geel A correlative triad of gadolinium-DTPA MRI, EDSS, and CSF-MBP in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone Neurology 42 1 1992 63 67
83. S.T. Frequin, F. Barkhof, K.J. Lamers, and O.R. Hommes The effects of high-dose methylprednisolone on gadolinium-enhanced magnetic resonance imaging and cerebrospinal fluid measurements in multiple sclerosis J Neuroimmunol 40 1992 265 272
84. D.H. Miller, A.J. Thompson, S.P. Morrissey, D.G. MacManus, S.G. Moore, and B.E. Kendall High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect J Neurol Neurosurg Psychiatry 55 6 1992 450 453
85. F. Barkhof, M.W. Tas, S.T. Frequin, P. Scheltens, O.R. Hommes, and J.J. Nauta Limited duration of the effect of methylprednisolone on changes on MRI in multiple sclerosis Neuroradiology 36 5 1994 382 387
86. C. Gasperini, C. Pozzilli, S. Bastianello, T. Koudriavtseva, A. Colleluori, and E. Millefiorini The influence of clinical relapses and steroid therapy on the development of Gd-enhancing lesions: a longitudinal MRI study in relapsing-remitting multiple sclerosis patients Acta Neurol Scand 95 4 1997 201 207
87. C. Gasperini, C. Pozzilli, S. Bastianello, T. Koudriavtseva, S. Galgani, and E. Millefiorini Effect of steroids on Gd-enhancing lesions before and during recombinant beta interferon 1a treatment in relapsing remitting multiple sclerosis Neurology 50 2 1998 403 406
88. R. Kapoor, D.H. Miller, S.J. Jones, G.T. Plant, A. Brusa, and A. Gass Effects of intravenous methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis Neurology 50 1 1998 230 237
89. F. Sellebjerg, C.V. Jensen, H.B. Larsson, and J.L. Frederiksen Gadolinium-enhanced magnetic resonance imaging predicts response to methylprednisolone in multiple sclerosis Mult Scler 9 2003 102 107
90. D. Uhlenbrock, E. Herbe, D. Seidel, and W. Gehlen One-year MR imaging follow-up of patients with multiple sclerosis under cortisone therapy Neuroradiology 31 1989 3 7
91. M. Brainin, A. Neuhold, T. Reisner, E. Maida, S. Lang, and L. Deecke Changes within the "normal" cerebral white matter of multiple sclerosis patients during acute attacks and during high-dose cortisone therapy assessed by means of quantitative MRI J Neurol Neurosurg Psychiatry 52 12 1989 1355 1359
92. M.E. Smith, L.A. Stone, P.S. Albert, J.A. Frank, R. Martin, and M. Armstrong Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions Ann Neurol 33 5 1993 480 489
93. R.L. Oliveri, G. Sibilia, P. Valentino, C. Russo, N. Romeo, and A. Quattrone Pulsed methylprednisolone induces a reversible impairment of memory in patients with relapsing-remitting multiple sclerosis Acta Neurol Scand 97 6 1998 366 369
94. N.D. Richert, J.L. Ostuni, C.N. Bash, T.P. Leist, H.F. McFarland, and J.A. Frank Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis Mult Scler 7 1 2001 49 58
95. M.F. Schocke, T. Berger, S.R. Felber, C. Wolf, F. Deisenhammer, and C. Kremser Serial contrast-enhanced magnetic resonance imaging and spectroscopic imaging of acute multiple sclerosis lesions under high-dose methylprednisolone therapy Neuroimage 20 2 2003 1253 1263
96. F. Louarn, J.L. Mas, and J.D. Degos Central nervous system involvement in systemic lupus erythematosus Rev Neurol 140 1984 110 116
97. E. Kinnunen, P. Jarvinen, L. Ketonen, and R. Sepponen Co-twin control study on cerebral manifestations of systemic lupus erythematosus Acta Neurol Scand 88 1993 422 426
98. N.B. Gaylis, R.D. Altman, S. Ostrov, and R. Quencer The selective value of computed tomography of the brain in cerebritis due to systemic lupus erythematosus J Rheumatol 9 1982 850 854
99. S.G. Ostrov, R.M. Quencer, N.B. Gaylis, and R.D. Altman Cerebral atrophy in systemic lupus erythematosus: steroid- or disease-induced phenomenon? AJNR Am J Neuroradiol 3 1982 21 23
100. W. Spiegel, S.J. McGeady, and H.C. Mansmann Jr. Cerebral cortical atrophy and central nervous system (CNS) symptoms in a steroid-treated child with asthma J Allergy Clin Immunol 89 1992 918 919
101. V.A. Zanardi, L.A. Magna, and L.T. Costallat Cerebral atrophy related to corticotherapy in systemic lupus erythematosus (SLE) Clin Rheumatol 20 2001 245 250
102. S.J. Hickman, R. Kapoor, S.J. Jones, D.R. Altmann, G.T. Plant, and D.H. Miller Corticosteroids do not prevent optic nerve atrophy following optic neuritis J Neurol Neurosurg Psychiatry 74 8 2003 1139 1141